{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:40:03Z","timestamp":1792690803154,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ondokuz May\u0131s University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Unlike somatotroph tumors, the data on correlates of tumor granulation patterns in functional TPIT lineage pituitary neuroendocrine tumors (corticotroph tumors) have been less uniformly documented in most clinical series. This study evaluated characteristics of 41 well-characterized functional corticotroph tumors consisting of 28 densely granulated corticotroph tumors (DGCTs) and 13 sparsely granulated corticotroph tumors (SGCTs) with respect to preoperative clinical and radiological findings, tumor proliferative activity (including mitotic count and Ki-67 labeling index), and postoperative early biochemical remission rates. The median (interquartile range (IQR)) tumor size was significantly larger in the SGCT group [16.00 (16.00) mm in SGCT vs 8.5 (9.75) mm in DGCT, <jats:italic>p<\/jats:italic>\u2009=\u20090.049]. T2-weighted signal intensity and T2 intensity (quantitative) did not yield statistical significance based on tumor granulation; however, the T2 intensity-to-white matter ratio was significantly higher in SGCTs (<jats:italic>p<\/jats:italic>\u2009=\u20090.049). The median (IQR) Ki-67 labeling index was 2.00% (IQR 1.00%) in the DGCT group and 4.00% (IQR 7.00%) in the SGCT group (<jats:italic>p<\/jats:italic>\u2009=\u20090.043). The mitotic count per 2 mm<jats:sup>2<\/jats:sup> was higher in the SGCT group (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). In the multivariate analysis, the sparse granulation pattern (SGCT) remained an independent predictor of a lower probability of early biochemical remission irrespective of the tumor size and proliferative activity (<jats:italic>p<\/jats:italic>\u2009=\u20090.012). The current study further supports the impact of tumor granulation pattern as a biologic variable and warrants the detailed histological subtyping of functional corticotroph tumors as indicated in the WHO classification of pituitary neuroendocrine tumors. More importantly, the assessment of the quantitative T2 intensity-to-white matter ratio may serve as a preoperative radiological harbinger of SGCTs.\n<\/jats:p>","DOI":"10.1007\/s12022-024-09819-y","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T12:03:53Z","timestamp":1721822633000},"page":"185-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Granulation Patterns of Functional Corticotroph Tumors Correlate with Tumor Size, Proliferative Activity, T2 Intensity-to-White Matter Ratio, and Postsurgical Early Biochemical Remission"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2743-957X","authenticated-orcid":false,"given":"Elif Tutku","family":"Durmu\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3437-5348","authenticated-orcid":false,"given":"Mehmet","family":"Kefeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-8427","authenticated-orcid":false,"given":"Sultan","family":"\u00c7al\u0131\u015fkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-7163","authenticated-orcid":false,"given":"Kerim","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-9857","authenticated-orcid":false,"given":"Mustafa Arda","family":"Onar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-0781","authenticated-orcid":false,"given":"Ramis","family":"\u00c7olak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3964-5079","authenticated-orcid":false,"given":"Bu\u011fra","family":"Durmu\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2146-3621","authenticated-orcid":false,"given":"Cengiz","family":"Cokluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-6365","authenticated-orcid":false,"given":"Ay\u015feg\u00fcl","family":"Atmaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"issue":"12","key":"9819_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD. Consensus on diagnosis and management of Cushing's disease: a guideline update. The lancet Diabetes & Endocrinology 2021, 9(12):847-875.","journal-title":"The lancet Diabetes & Endocrinology"},{"key":"9819_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12022-019-09582-5","volume":"30","author":"N Qiao","year":"2019","unstructured":"Qiao N, Swearingen B, Hedley-Whyte ET, Tritos NA. The utility of intraoperative cytological smear and frozen section in the surgical management of patients with Cushing\u2019s disease due to pituitary microadenomas. Endocrine Pathology 2019, 30:180-188.","journal-title":"Endocrine Pathology"},{"issue":"1","key":"9819_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO classification of pituitary tumors. Endocrine Pathology 2022, 33(1):6-26.","journal-title":"Endocrine Pathology"},{"key":"9819_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12022-021-09663-4","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O, Ezzat S. Genomics and epigenomics of pituitary tumors: what do pathologists need to know? Endocrine pathology 2021, 32:3-16.","journal-title":"Endocrine pathology"},{"issue":"4","key":"9819_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","volume":"22","author":"O Mete","year":"2012","unstructured":"Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain pathology 2012, 22(4):443-453.","journal-title":"Brain pathology"},{"issue":"5","key":"9819_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0344-0338(88)80018-9","volume":"183","author":"W Saeger","year":"1988","unstructured":"Saeger W, Geisler F, L\u00fcdecke D. Pituitary pathology in Cushing's disease. Pathology-Research and Practice 1988, 183(5):592-595.","journal-title":"Pathology-Research and Practice"},{"key":"9819_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/BF01605073","volume":"419","author":"WA Reuss","year":"1991","unstructured":"Reuss WA, Saeger W, L\u00fcdecke DK. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome. Virchows Archiv A 1991, 419:395-401.","journal-title":"Virchows Archiv A"},{"issue":"1","key":"9819_CR8","first-page":"9","volume":"35","author":"S\u00c7 Do\u011fan\u015fen","year":"2019","unstructured":"Do\u011fan\u015fen S\u00c7, Bilgi\u00e7 B, Yalin GY, Tanrikulu S, Yarman S. Clinical significance of granulation pattern in corticotroph pituitary adenomas. Turk Patoloji Derg 2019, 35(1):9-14.","journal-title":"Turk Patoloji Derg"},{"key":"9819_CR9","doi-asserted-by":"crossref","unstructured":"Rak B, Maksymowicz M, P\u0119kul M, Zieli\u0144ski G. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing\u2019s Disease. Frontiers in endocrinology 2021:564.","DOI":"10.3389\/fendo.2021.672178"},{"issue":"4","key":"9819_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/EJE-15-1226","volume":"174","author":"P Witek","year":"2016","unstructured":"Witek P, Zieli\u0144ski G, Szamotulska K, Maksymowicz M, Kami\u0144ski G. Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre. European Journal of Endocrinology 2016, 174(4):539.","journal-title":"European Journal of Endocrinology"},{"issue":"2","key":"9819_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EJE-15-0689","volume":"174","author":"K Hayashi","year":"2016","unstructured":"Hayashi K, Inoshita N, Kawaguchi K, Ibrahim Ardisasmita A, Suzuki H, Fukuhara N, Okada M, Nishioka H, Takeuchi Y, Komada M. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease. European Journal of Endocrinology 2016, 174(2):213-226.","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"9819_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12020-016-0984-8","volume":"56","author":"R Pivonello","year":"2017","unstructured":"Pivonello R, De Martino MC, De Leo M, Simeoli C, Colao A. Cushing\u2019s disease: the burden of illness. Endocrine 2017, 56(1):10-18.","journal-title":"Endocrine"},{"issue":"3","key":"9819_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s11102-022-01215-1","volume":"25","author":"C Perez-Vega","year":"2022","unstructured":"Perez-Vega C, Ramos-Fresnedo A, Tripathi S, Domingo RA, Ravindran K, Almeida JP, Peterson J, Trifiletti DM, Chaichana KL, Quinones-Hinojosa A. Treatment of recurrent and persistent Cushing\u2019s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis. Pituitary 2022, 25(3):540-549.","journal-title":"Pituitary"},{"issue":"11","key":"9819_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1159\/000509221","volume":"111","author":"C Dai","year":"2021","unstructured":"Dai C, Fan Y, Liu X, Bao X, Yao Y, Wang R, Feng M. Predictors of Immediate Remission after Surgery in Cushing\u2019s Disease Patients: a large retrospective study from a single center. Neuroendocrinology 2021, 111(11):1141-1150.","journal-title":"Neuroendocrinology"},{"issue":"5","key":"9819_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/jpm12050798","volume":"12","author":"NV Kuritsyna","year":"2022","unstructured":"Kuritsyna NV, Tsoy UA, Cherebillo VY, Paltsev AA, Ryzhkov AV, Ryazanov PA, Ryzhkov VK, Grineva EN. A Comprehensive Approach to Predicting the Outcomes of Transsphenoidal Endoscopic Adenomectomy in Patients with Cushing\u2019s Disease. Journal of Personalized Medicine 2022, 12(5):798.","journal-title":"Journal of Personalized Medicine"},{"issue":"1","key":"9819_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11102-014-0567-8","volume":"18","author":"G Aranda","year":"2015","unstructured":"Aranda G, Ense\u00f1at J, Mora M, Puig-Domingo M, Mart\u00ednez de Osaba M, Casals G, Verger E, Ribalta M, Hanzu F, Halperin I. Long-term remission and recurrence rate in a cohort of Cushing\u2019s disease: the need for long-term follow-up. Pituitary 2015, 18(1):142-149.","journal-title":"Pituitary"},{"issue":"1","key":"9819_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2265.1993.tb00976.x","volume":"38","author":"D McCance","year":"1993","unstructured":"McCance D, Gordon D, Fannin T, Hadden D, Kennedy L, Sheridan B, Atkinson A. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clinical Endocrinology 1993, 38(1):79-86.","journal-title":"Clinical Endocrinology"},{"issue":"11","key":"9819_CR18","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3390\/jcm8111951","volume":"8","author":"H Nishioka","year":"2019","unstructured":"Nishioka H, Yamada S. Cushing\u2019s disease. Journal of clinical medicine 2019, 8(11):1951.","journal-title":"Cushing\u2019s disease. Journal of clinical medicine"},{"key":"9819_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.620005","volume":"12","author":"A Akirov","year":"2021","unstructured":"Akirov A, Larouche V, Shimon I, Asa SL, Mete O, Sawka AM, Gentili F, Ezzat S. Significance of Crooke's hyaline change in nontumorous corticotrophs of patients with Cushing disease. Frontiers in Endocrinology 2021, 12:620005.","journal-title":"Frontiers in Endocrinology"},{"issue":"5","key":"9819_CR20","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2008, 93(5):1526-1540.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"9819_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/17446651.2020.1802243","volume":"15","author":"C Capatina","year":"2020","unstructured":"Capatina C, Hinojosa-Amaya JM, Poiana C, Fleseriu M. Management of patients with persistent or recurrent Cushing\u2019s disease after initial pituitary surgery. Expert Review of Endocrinology & Metabolism 2020, 15(5):321-339.","journal-title":"Expert Review of Endocrinology & Metabolism"},{"issue":"2","key":"9819_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1530\/ERC-14-0305","volume":"22","author":"I Potorac","year":"2015","unstructured":"Potorac I, Petrossians P, Daly AF, Schillo F, Ben Slama C, Nagi S, Sahnoun M, Brue T, Girard N, Chanson P. Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. Endocr Relat Cancer 2015, 22(2):169-177.","journal-title":"Endocr Relat Cancer"},{"issue":"1088","key":"9819_CR23","doi-asserted-by":"publisher","first-page":"20180088","DOI":"10.1259\/bjr.20180088","volume":"91","author":"K Aslan","year":"2018","unstructured":"Aslan K, Gunbey HP, Tomak L, Incesu L. The diagnostic value of using combined MR diffusion tensor imaging parameters to differentiate between low-and high-grade meningioma. The British journal of radiology 2018, 91(1088):20180088.","journal-title":"The British journal of radiology"},{"issue":"4","key":"9819_CR24","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993, 33(4):610-618.","journal-title":"Neurosurgery"},{"issue":"7","key":"9819_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrendo.2014.64","volume":"10","author":"A Di Ieva","year":"2014","unstructured":"Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K. Aggressive pituitary adenomas\u2014diagnosis and emerging treatments. Nature Reviews Endocrinology 2014, 10(7):423-435.","journal-title":"Nature Reviews Endocrinology"},{"issue":"6","key":"9819_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/21548331.1979.11707562","volume":"14","author":"J Hardy","year":"1979","unstructured":"Hardy J. The transsphenoidal surgical approach to the pituitary. Hospital practice 1979, 14(6):81-89.","journal-title":"Hospital practice"},{"issue":"9","key":"9819_CR27","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/epi.13843","volume":"58","author":"GP Winston","year":"2017","unstructured":"Winston GP, Vos SB, Burdett JL, Cardoso MJ, Ourselin S, Duncan JS. Automated T2 relaxometry of the hippocampus for temporal lobe epilepsy. Epilepsia 2017, 58(9):1645-1652.","journal-title":"Epilepsia"},{"key":"9819_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocrine Pathology 2017, 28:228-243.","journal-title":"Endocrine Pathology"},{"key":"9819_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12022-020-09646-x","volume":"31","author":"O Mete","year":"2020","unstructured":"Mete O, Asa SL. Structure, function, and morphology in the classification of pituitary neuroendocrine tumors: the importance of routine analysis of pituitary transcription factors. Endocrine Pathology 2020, 31:330-336.","journal-title":"Endocrine Pathology"},{"key":"9819_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12022-021-09671-4","volume":"32","author":"O Mete","year":"2021","unstructured":"Mete O, Ezzat S, Perry A, Yamada S, Uccella S, Grossman AB, Asa SL. The pangenomic classification of pituitary neuroendocrine tumors: quality histopathology is required for accurate translational research. Endocrine Pathology 2021, 32:415-417.","journal-title":"Endocrine Pathology"},{"issue":"2","key":"9819_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12022-021-09678-x","volume":"32","author":"SL Asa","year":"2021","unstructured":"Asa SL. Challenges in the diagnosis of pituitary neuroendocrine tumors. Endocrine Pathology 2021, 32(2):222-227.","journal-title":"Endocrine Pathology"},{"issue":"8","key":"9819_CR32","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1210\/jc.2005-0070","volume":"90","author":"YS Woo","year":"2005","unstructured":"Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar F, Sabin I, Jenkins PJ, Monson JP, Besser GM, Grossman AB. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. The Journal of Clinical Endocrinology & Metabolism 2005, 90(8):4963-4969.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"9819_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3171\/JNS\/2008\/108\/01\/0009","volume":"108","author":"BM Hofmann","year":"2008","unstructured":"Hofmann BM, Hlavac M, Martinez R, Buchfelder M, M\u00fcller OA, Fahlbusch R. Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. Journal of neurosurgery 2008, 108(1):9-18.","journal-title":"Journal of neurosurgery"},{"issue":"2","key":"9819_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1227\/01.NEU.0000313117.35824.9F","volume":"63","author":"CG Patil","year":"2008","unstructured":"Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws Jr ER. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Neurosurgery 2008, 63(2):266-271.","journal-title":"Neurosurgery"},{"key":"9819_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11102-020-01096-2","volume":"24","author":"AA Swanson","year":"2021","unstructured":"Swanson AA, Erickson D, Donegan DM, Jenkins SM, Van Gompel JJ, Atkinson JL, Erickson BJ, Giannini C. Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly. Pituitary 2021, 24:192-206.","journal-title":"Pituitary"},{"issue":"6","key":"9819_CR36","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1210\/clinem\/dgab069","volume":"106","author":"EC Coopmans","year":"2021","unstructured":"Coopmans EC, Postma MR, Wolters TL, van Meyel SW, Netea-Maier R, van Beek AP, Neggers SJ. Predictors for remission after transsphenoidal surgery in acromegaly: A Dutch multicenter study. The Journal of Clinical Endocrinology & Metabolism 2021, 106(6):1783-1792.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"9819_CR37","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/cen.14574","volume":"96","author":"Y Wu","year":"2022","unstructured":"Wu Y, Cai Y, Rui W, Tang Y, Yang Z, He M, Ye H, Wang Y, Zhao Y, Ma Z. Contrast\u2010enhanced 3D\u2010T2\u2010weighted SPACE sequence for MRI detection and localization of adrenocorticotropin (ACTH)\u2010secreting pituitary microadenomas. Clinical Endocrinology 2022, 96(4):578-588.","journal-title":"Clinical Endocrinology"},{"issue":"4","key":"9819_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11102-018-0877-3","volume":"21","author":"SC Dogansen","year":"2018","unstructured":"Dogansen SC, Yalin GY, Tanrikulu S, Tekin S, Nizam N, Bilgic B, Sencer S, Yarman S. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas. Pituitary 2018, 21(4):347-354.","journal-title":"Pituitary"},{"key":"9819_CR39","doi-asserted-by":"crossref","unstructured":"Ragate DC, Memon SS, Sarathi V, Lila AR, Channaiah CY, Patil VA, Karlekar M, Barnabas R, Thakkar H, Shah NS. Pituitary apoplexy in cushing\u2019s disease: a single center study and systematic literature review. Pituitary 2024:1\u201310.","DOI":"10.1007\/s11102-024-01411-1"},{"key":"9819_CR40","doi-asserted-by":"crossref","unstructured":"Liu T, Rossiter JP, Houlden RL, Awad S. Sparsely Granulated Corticotroph Pituitary Macroadenoma Presenting With Pituitary Apoplexy Resulting in Remission of Hypercortisolism. AACE Clinical Case Reports 2022.","DOI":"10.1016\/j.aace.2022.04.003"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-024-09819-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T03:41:03Z","timestamp":1726026063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-024-09819-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["9819"],"URL":"https:\/\/doi.org\/10.1007\/s12022-024-09819-y","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"15 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ondokuz Mayis University Faculty of Medicine\u2019s Medical Ethics Committee (IRB No: OMU KAEK 2019\/881) approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors approved the final version and publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Ozgur Mete is the Editor-in-Chief of Endocrine Pathology. This article is handled by an independent senior editor as per Springer Nature\u2019s policies. Dr. Mehmet Kefeli is an Editorial Board member of Endocrine Pathology. The remaining authors have no conflicts of interest to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}